Press Release Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline Aug 21
Press Release Ipsen nominates Catherine Bradley to its Board of Directors as independent Director Jul 29
Press Release Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen’s Rare Disease pipeline Jul 22